Ardelyx bowel drug succeeds in mid-stage trial

(Reuters) - Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movement compared with a placebo in a mid-stage study involving 371 patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news